Fri, 13 Sep 2013 | BUSINESS SALE
Healthcare software provider EMIS Group, part of ECI Partners, has acquired Bolton-headquartered Ascribe Group.
The business sale has been conditionally approved for £57.5 million in a deal that is expected to deliver “significant growth prospects” for the business.
Ascribe sells IT systems for pharmacy, administration and accident and emergency use to the NHS and overseas health service providers. It recently posted an operating profit of £4.3 million.
EMIS is paying for the company's share capital, which is valued at £12.5 million. However, it is also paying £40.4 million for the firm's outstanding loan notes and preference shares and a further £4.6 million to cover external bank debt.
The buyer operates in a similar sector, providing clinical software and related services to GP practices and other healthcare practitioners.
Chief executive of Ascribe, Stephen Critchlow, commented on the deal: “Our shared vision is for patients to benefit from all the information collected about their health and care across primary, secondary, social and community settings.
“Combining our integrated cross-organisational products and services will enable us to offer a unique proposition that benefits customers both in the UK and overseas."
He added that the firm sees EMIS as a “natural partner to take the Ascribe business to the next stage of its development”.
_________________________________________________________________________
Related information:
View the latest medical businesses for sale
Represents an opportunity for an acquirer seeking a private dentistry based in Cheshire, and boasting 3 well-equipped, modern surgeries.
FREEHOLD
This is a denovo dentistry opportunity including land and planning permission granted. Principal is happy to stay-on and accept an earn-out, demonstrating the safety of your investment.
FREEHOLD
Boasting 3 surgeries but with the potential for at least 2 more within the current premises this practice can handle any future growth easily.
FREEHOLD
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.